Skip to main content

Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Entrada Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+2 vs. Q4 2021
Shares held
25.9M
+506.3K (+2.0%) vs. Q4 2021
Total value
$242.8M
−$191.0M (−44.0%) vs. Q4 2021
New holders
8
14 more added
Sold out
6
12 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 46 institutionsQ1 2022: 48 institutionsQ2 2022: 38 institutionsQ3 2022: 33 institutionsQ4 2022: 47 institutionsQ1 2023: 53 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 62 institutionsQ1 2024: 77 institutionsQ2 2024: 84 institutionsQ3 2024: 97 institutionsQ4 2024: 102 institutionsQ1 2025: 110 institutionsQ2 2025: 107 institutionsQ3 2025: 116 institutionsQ4 2025: 113 institutionsQ1 2026: 119 institutionsQ2 2026: 128 institutions
Value heldQ1 2022: $242.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $433.8MQ1 2022: $242.8MQ2 2022: $301.8MQ3 2022: $386.4MQ4 2022: $334.2MQ1 2023: $361.0MQ2 2023: $389.9MQ3 2023: $411.4MQ4 2023: $396.6MQ1 2024: $368.8MQ2 2024: $423.1MQ3 2024: $481.1MQ4 2024: $529.8MQ1 2025: $274.5MQ2 2025: $198.8MQ3 2025: $164.8MQ4 2025: $251.0MQ1 2026: $321.4MQ2 2026: $214.4M
Institutions holding TRDA and their total value by quarter
QuarterHoldersValue
Q2 2026128$214.4M
Q1 2026119$321.4M
Q4 2025113$251.0M
Q3 2025116$164.8M
Q2 2025107$198.8M
Q1 2025110$274.5M
Q4 2024102$529.8M
Q3 202497$481.1M
Q2 202484$423.1M
Q1 202477$368.8M
Q4 202362$396.6M
Q3 202355$411.4M
Q2 202356$389.9M
Q1 202353$361.0M
Q4 202247$334.2M
Q3 202233$386.4M
Q2 202238$301.8M
Q1 202248$242.8M
Q4 202146$433.8M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding TRDA in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP4,704,419$44.2M0.25%00.0%Unchanged
MPM Asset Management LLC4,425,784$41.6M14.20%00.0%Unchanged
5AM Venture Management, LLC4,408,379$41.4M9.04%00.0%Unchanged
Wellington Management Group LLP2,543,102$23.8M0.00%−570,904−18.3%Reduced
Price T Rowe Associates Inc2,494,714$23.4M0.00%+474,077+23.5%Added
Redmile Group, LLC1,954,419$18.4M0.57%−10.0%Reduced
FMR LLC876,794$8.23M0.00%+590,994+206.8%Added
StepStone Group LP761,277$7.15M0.53%00.0%Unchanged
TCG Crossover Management, LLC663,694$6.13M2.46%00.0%Unchanged
72 Investment Holdings, LLC509,023$4.78M5.23%−10.0%Reduced
BlackRock Inc.445,520$4.18M0.00%+1,094+0.2%Added
Goldman Sachs Group Inc445,455$4.18M0.00%00.0%Unchanged
Vanguard Group Inc430,404$4.04M0.00%+5,452+1.3%Added
Geode Capital Management, LLC177,733$1.67M0.00%+15,546+9.6%Added
Nan Fung Group Holdings Ltd173,582$1.63M0.77%+173,582New
State Street Corp151,194$1.42M0.00%+70,075+86.4%Added
Suvretta Capital Management, LLC106,000$995.0K0.03%00.0%Unchanged
Moore Capital Management, LP105,000$986.0K0.03%00.0%Unchanged
Northern Trust Corp90,258$847.0K0.00%+10,775+13.6%Added
Charles Schwab Investment Management Inc68,704$646.0K0.00%+4,685+7.3%Added
Citadel Advisors LLC64,399$604.0K0.00%−44,395−40.8%Reduced
TD Asset Management Inc57,675$542.0K0.00%00.0%Unchanged
Walleye Capital LLC44,652$419.0K0.01%+44,652New
Manufacturers Life Insurance Company, The41,175$393.1K0.00%+41,175New
Bank of New York Mellon Corp21,933$206.0K0.00%+8,276+60.6%Added
Bank of America Corp20,871$196.0K0.00%−1,971−8.6%Reduced
Ghisallo Capital Management LLC15,000$141.0K0.02%00.0%Unchanged
Nuveen Asset Management, LLC13,872$130.0K0.00%00.0%Unchanged
Renaissance Technologies LLC11,800$111.0K0.00%−1,773−13.1%Reduced
Morgan Stanley8,361$78.0K0.00%+4,199+100.9%Added
American International Group, Inc.5,223$49.0K0.00%+356+7.3%Added
Deutsche Bank AG4,959$47.0K0.00%−608−10.9%Reduced
JPMorgan Chase & Co4,934$46.0K0.00%+1,440+41.2%Added
New York State Common Retirement Fund4,880$46.0K0.00%+4,880New
California State Teachers Retirement System4,446$42.0K0.00%−570−11.4%Reduced
Tower Research Capital LLC (TRC)2,485$23.0K0.00%+7+0.3%Added
Wells Fargo & Company2,285$21.0K0.00%−3,035−57.0%Reduced
STRS Ohio2,100$19.0K0.00%00.0%Unchanged
Barclays PLC1,709$16.0K0.00%+1,709New
UBS Group AG1,447$13.0K0.00%−1,367−48.6%Reduced
Amalgamated Bank1,350$13.0K0.00%+1,350New
Amalgamated Financial Corp.1,350$13.0K0.00%+1,350New
State of Wyoming1,060$10.0K0.01%+829+358.9%Added
Legal & General Group Plc848$8.00K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.708$7.00K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC700$7.00K0.00%+700New
Royal Bank of Canada646$6.00K0.00%−1,217−65.3%Reduced
Citigroup Inc413$4.00K0.00%−1,980−82.7%Reduced
Avidity Partners Management LP0$00.00%−255,000−100.0%Sold out
Millennium Management LLC0$00.00%−46,504−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−11,090−100.0%Sold out
Caas Capital Management LP0$00.00%−10,000−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−300−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−215−100.0%Sold out